Why 46% of Bill Gates' fund is now concentrated in just 2 stocks

The Gates Foundation Trust no longer owns any Microsoft shares, and its roughly $33 billion public equity portfolio is now about 46% concentrated in Berkshire Hathaway and Waste Management. The article highlights a major portfolio reallocation and concentration shift rather than operating results or a direct market catalyst. The news is primarily relevant as a governance and positioning update, with limited immediate price impact.

Analysis

The key signal is not the absence of Microsoft, but the concentration into two mature, cash-generative franchises that behave more like capital allocators than operating bets. That tends to reduce portfolio volatility but also makes the trust a quasi-duration instrument on defensive secular compounders: Berkshire for financial optionality and WM for pricing power plus recurring cash flow. In market terms, this is supportive for both names at the margin because large, slow-moving pools of capital often anchor valuations during drawdowns and compress downside realized vol.

Second-order, the move subtly reframes MSFT positioning. If one of the most visible long-term capital pools has completed an exit, it does not change fundamentals, but it can remove a “quality-at-any-price” halo and make the stock more sensitive to flow than narrative on the margin. That matters most if AI capex enthusiasm cools or if mega-cap growth leadership broadens out, because MSFT has been owned as both an earnings compounder and a core index weight; once the marginal anchor buyer is gone, the stock can trade more like a consensus winner than a scarcity asset.

For BRK.B, the bigger implication is that the market may continue to underwrite it as a deferred cash deployment vehicle rather than a pure operating company, which supports the multiple as long as rates stay elevated and dispersion remains high. WM is the more interesting relative-value beneficiary: a boring monopoly-like asset with visible pricing power and low economic sensitivity should command a premium if investors keep rotating toward balance-sheet resilience. The contrarian view is that this concentration may be less a bullish endorsement than a governance/liquidity optimization, so chasing the names purely on headline signal is likely overdone unless the broader market enters a defensiveness regime.

Key Decisions for Investors

• Long BRK.B vs. short XLY on a 1-3 month horizon: if the market de-risks, Berkshire should hold up better as a diversified cash compounder while consumer cyclicals bear multiple compression; target 4-6% spread with tight stop if risk-on broadens.
• Add WM on a pullback over the next 2-4 weeks: treat as a low-beta pricing-power defensive with high free-cash-flow visibility; expect lower drawdown than the market in a volatility spike, with upside mainly from multiple support rather than earnings revisions.
• Fade a knee-jerk MSFT selloff only if it is flow-driven and not fundamentals-driven: buy 3-6 month downside puts financed by selling out-of-the-money calls if implied vol stays elevated, because any “founder-exit” narrative can overshoot before mean-reverting.